The state Duma adopted the law on the purchase in Russia of unregistered medicines
The state Duma at plenary session on Wednesday approved the governmental law on interchangeability of medicines taking into account the amendments which the government has the right to purchase unregistered Russian agents.
The state Duma at plenary session on Wednesday approved the governmental law on interchangeability of medicines taking into account the amendments which the government has the right to purchase unregistered Russian agents.
legislative act provides for the right of the government of the Russian Federation to establish the rules and features a choice of interchangeable drugs. The draft law clarifies the concept of "interchangeable drug" by a number of parameters and conceptual apparatus will be uniform. In addition, the bill is determined by what formula will determine the cost of public procurement have interchangeable drugs.
As before explained to the correspondent the head of the state Duma on health protection Dmitry Morozov, the law really decides the issue of conceptual apparatus of relatively new drugs that appear on the market.
the legislative act also establishes the range of possibilities of the government purchase in Russia of unregistered medicines by the decision of the medical Commission.
in the last month of summer was stated about detention in capital of Russia of the woman who ordered for your child abroad is not registered in the Russian Federation " Frisium ". The public and human rights activists called the situation " absurd and inhumane ", his concern was expressed In the leadership of the Russian Federation. The Federal customs service said on excitation of criminal case, a woman took him in As a witness. Later, the Prosecutor declared excitation of criminal case on smuggling across the border " Frisium ".
Russian Prime Minister Medvedev D. A. said that gave the order to allocate money for the purchase of medicines for children suffering from chronic diseases. According to his statement, certain forms of drugs are currently produced abroad, manufacturers do not register them in Russia. He noticed that before the end of 2023, the challenge is to establish production of the desired form in Russia.
<span style="color:darkgray